Loureirin B Ameliorates Glycolipid Metabolism Disorders in Ob/ob Mice by Regulating Bile Acid Levels and Modulating Gut Microbiota Composition
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202401793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Junyang Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, State Key Laboratory of Component-based Chinese Medicine, Tianjin Key Laboratory of Therapeutic Substance of Tradit…. Hauptthemen laut MEDLINE: Bile Acids and Salts, Gastrointestinal Microbiome, Glycolipids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Loureirin B (LB), an active component of Resina Draconis, exhibits hypoglycemic and hypolipidemic effects; however, its mode of action remains unclear. Here, ob/ob mice were utilized to investigate the effects of LB on the regulation of glucolipid metabolism disorders. Non‐targeted metabolomics and 16S rDNA sequencing were performed to elucidate the potential mechanisms involved. Results indicated that LB treatment (45 mg/kg) significantly improved glucose intolerance and insulin resistance, reduced lipid levels, and alleviated hepatic steatosis. Non‐targeted metabolomics analysis revealed that LB treatment regulated bile acid levels. Quantification of liver bile acids demonstrated that LB treatment significantly decreased the ratio of 12α‐OH to non‐12α‐OH bile acids in the liver. 16S rDNA sequencing results showed that LB treatment increased the abundance of short‐chain fatty acid‐producing microbiota while decreasing the abundance of bile salt hydrolase (BSH) enzyme‐producing microbiota. In conclusion, LB ameliorates glucolipid metabolism disorders by regulating liver bile acid levels and modulating the composition of the gut microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, State Key Laboratory of Component-based Chinese Medicine, Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medi…
ORCID-Profile: Xinchi Feng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Zhang, X., Li, G., Ge, J., & Feng, X. (2025). Loureirin B Ameliorates Glycolipid Metabolism Disorders in Ob/ob Mice by Regulating Bile Acid Levels and Modulating Gut Microbiota Composition. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401793
Vancouver
Zhang J, Zhang X, Li G, Ge J, Feng X. Loureirin B Ameliorates Glycolipid Metabolism Disorders in Ob/ob Mice by Regulating Bile Acid Levels and Modulating Gut Microbiota Composition. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401793
BibTeX
@article{Zhang2025,
author = {Zhang, Junyang and Zhang, Xiaoyan and Li, Gen and Ge, Jun and Feng, Xinchi},
title = {Loureirin B Ameliorates Glycolipid Metabolism Disorders in Ob/ob Mice by Regulating Bile Acid Levels and Modulating Gut Microbiota Composition},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202401793}
}
EUVIMED